Table of Contents Author Guidelines Submit a Manuscript
Journal of Ophthalmology
Volume 2014, Article ID 820853, 6 pages
http://dx.doi.org/10.1155/2014/820853
Clinical Study

The Association between Diabetic Retinopathy and Levels of Ischemia-Modified Albumin, Total Thiol, Total Antioxidant Capacity, and Total Oxidative Stress in Serum and Aqueous Humor

1Department of Ophthalmology, Cumhuriyet University School of Medicine, 58140 Sivas, Turkey
2Department of Ophthalmology, Ulus State Hospital, Ankara, Turkey
3Department of Biochemistry, Cumhuriyet University School of Medicine, 58140 Sivas, Turkey

Received 24 May 2014; Revised 14 November 2014; Accepted 16 November 2014; Published 16 December 2014

Academic Editor: Tamer A. Macky

Copyright © 2014 Kadir Kirboga et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. H. Kempen, B. J. O'Colmain, M. C. Leske et al., “The prevalence of diabetic retinopathy among adults in the United States,” Archives of Ophthalmology, vol. 122, no. 4, pp. 552–563, 2004. View at Publisher · View at Google Scholar · View at Scopus
  2. M. Rema, S. Premkumar, B. Anitha, R. Deepa, R. Pradeepa, and V. Mohan, “Prevalence of diabetic retinopathy in urban India: the Chennai Urban Rural Epidemiology Study (CURES) eye study,” Investigative Ophthalmology and Visual Science, vol. 46, no. 7, pp. 2328–2333, 2005. View at Publisher · View at Google Scholar · View at Scopus
  3. R. B. Caldwell, M. Bartoli, M. A. Behzadian et al., “Vascular endothelial growth factor and diabetic retinopathy: pathophysiological mechanisms and treatment perspectives,” Diabetes/Metabolism Research and Reviews, vol. 19, no. 6, pp. 442–455, 2003. View at Publisher · View at Google Scholar · View at Scopus
  4. Q. Mohamed, M. C. Gillies, and T. Y. Wong, “Management of diabetic retinopathy: a systematic review,” The Journal of the American Medical Association, vol. 298, no. 8, pp. 902–916, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. D. Armstrong and F. Al-Awadi, “Lipid peroxidation and retinopathy in streptozotocin-induced diabetes,” Free Radical Biology and Medicine, vol. 11, no. 4, pp. 433–436, 1991. View at Publisher · View at Google Scholar · View at Scopus
  6. S. Hjortshøj, S. R. Kristensen, and J. Ravkilde, “Diagnostic value of ischemia-modified albumin in patients with suspected acute coronary syndrome,” The American Journal of Emergency Medicine, vol. 28, no. 2, pp. 170–176, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. S.-G. Ma, W. Xu, C.-L. Wei et al., “Role of ischemia-modified albumin and total homocysteine in estimating symptomatic lacunar infarction in type 2 diabetic patients,” Clinical Biochemistry, vol. 44, no. 16, pp. 1299–1303, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. F. S. Apple, A. H. Wu, J. Mair et al., “Committee on standardization of markers of cardiac damage of the IFCC. Future biomarkers for detection of ischemia and risk stratification in acute coronary syndrome,” Clinical Chemistry, vol. 51, pp. 810–824, 2005. View at Google Scholar
  9. A. Piwowar, M. Knapik-Kordecka, and M. Warwas, “Ischemia-modified albumin level in type 2 diabetes mellitus—preliminary report,” Disease Markers, vol. 24, no. 6, pp. 311–317, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. K. Ukinc, S. Eminagaoglu, H. O. Ersoz et al., “A novel indicator of widespread endothelial damage and ischemia in diabetic patients: ischemia-modified albumin,” Endocrine, vol. 36, no. 3, pp. 425–432, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Kaefer, S. J. Piva, J. A. M. de Carvalho et al., “Association between ischemia modified albumin, inflammation and hyperglycemia in type 2 diabetes mellitus,” Clinical Biochemistry, vol. 43, no. 4-5, pp. 450–454, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. A. Turk, I. Nuhoglu, A. Mentese, S. C. Karahan, H. Erdol, and C. Erem, “The relationship between diabetic retinopathy and serum levels of ischemia-modified albumin and malondialdehyde,” Retina, vol. 31, no. 3, pp. 602–608, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. P. di Mascio, M. E. Murphy, and H. Sies, “Antioxidant defense systems: the role of carotenoids, tocopherols, and thiols,” The American Journal of Clinical Nutrition, vol. 53, no. 1, pp. 194–200, 1991. View at Google Scholar · View at Scopus
  14. E. Cadenas, “Biochemistry of oxygen toxicity,” Annual Review of Biochemistry, vol. 58, pp. 79–110, 1989. View at Publisher · View at Google Scholar · View at Scopus
  15. A. A. Qutub and A. S. Popel, “Reactive oxygen species regulate hypoxia-inducible factor 1α differentially in cancer and ischemia,” Molecular and Cellular Biology, vol. 28, no. 16, pp. 5106–5119, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. K. Kadota, Y. Yui, R. Hattori, Y. Murohara, and C. Kawai, “Decreased sulfhydryl groups of serum albumin in coronary artery disease,” Japanese Circulation Journal, vol. 55, no. 10, pp. 937–941, 1991. View at Publisher · View at Google Scholar · View at Scopus
  17. M. Soszynski and G. Bartosz, “Decreas in accesible thiols as an indexof oxidative damage to membrane proteins,” Free Radical Biology & Medicine, vol. 23, pp. 463–469, 1997. View at Google Scholar
  18. A. Ceriello, N. Bortolotti, E. Falleti et al., “Total radical-trapping antioxidant parameter in NIDDM patients,” Diabetes Care, vol. 20, no. 2, pp. 194–197, 1997. View at Publisher · View at Google Scholar · View at Scopus
  19. L. M. Aiello, “Perspectives on diabetic retinopathy,” American Journal of Ophthalmology, vol. 136, no. 1, pp. 122–135, 2003. View at Publisher · View at Google Scholar · View at Scopus
  20. R. Klein, B. E. K. Klein, S. E. Moss, M. D. Davis, and D. L. DeMets, “Glycosylated hemoglobin predicts the incidence and progression of diabetic retinopathy,” The Journal of the American Medical Association, vol. 260, no. 19, pp. 2864–2871, 1988. View at Publisher · View at Google Scholar · View at Scopus
  21. “Grading diabetic retinopathy from stereoscopic color fundus photographs—an extension of the modified Airlie House classification. ETDRS report number 10. Early Treatment Diabetic Retinopathy Study Research Group,” Ophthalmology, vol. 98, supplement 5, pp. 786–806, 1991.
  22. L. Keating, J. R. Benger, R. Beetham et al., “The PRIMA study: presentation ischaemia-modified albumin in the emergency department,” Emergency Medicine Journal, vol. 23, no. 10, pp. 764–768, 2006. View at Publisher · View at Google Scholar · View at Scopus
  23. D. Bar-Or, J. V. Winkler, K. VanBenthuysen, L. Harris, E. Lau, and F. W. Hetzel, “Reduced albumin-cobalt binding with transient myocardial ischemia after elective percutaneous transluminal coronary angioplasty: a preliminary comparison to creatine kinase-MB, myoglobin, and troponin I,” American Heart Journal, vol. 141, no. 6, pp. 985–991, 2001. View at Publisher · View at Google Scholar · View at Scopus
  24. C. V. Pollack, W. F. Peacock, and R. W. Summers, “Ischemia-modified albumin (IMA) is useful in risk stratification of emergency department chest pain patients,” Academic Emergency Medicine, vol. 10, pp. 555–556, 2003. View at Google Scholar
  25. M. Montagnana, G. Lippi, A. Volpe et al., “Evaluation of cardiac laboratory markers in patients with systemic sclerosis,” Clinical Biochemistry, vol. 39, no. 9, pp. 913–917, 2006. View at Publisher · View at Google Scholar · View at Scopus
  26. A. Gunduz, A. Mentese, S. Turedi et al., “Serum ischaemia-modified albumin increases in critical lower limb ischaemia,” Emergency Medicine Journal, vol. 25, no. 6, pp. 351–353, 2008. View at Publisher · View at Google Scholar · View at Scopus
  27. S. Türedi, A. Gündüz, and A. Menteşe, “The value of ischemia-modified albumin in the diagnosis of pulmonary embolism,” American Journal of Emergency Medicine, vol. 25, no. 7, pp. 770–773, 2007. View at Publisher · View at Google Scholar
  28. A. Menteşe, U. Menteşe, and S. Türedi, “Effect of deep veinthrombosis on ischaemia—modified albumin levels,” Emergency Medicine Journal, vol. 25, pp. 811–814, 2008. View at Google Scholar
  29. A. Cherubini, C. Ruggiero, M. C. Polidori, and P. Mecocci, “Potential markers of oxidative stress in stroke,” Free Radical Biology and Medicine, vol. 39, no. 7, pp. 841–852, 2005. View at Publisher · View at Google Scholar · View at Scopus
  30. A. Collier, R. Wilson, H. Bradley, J. A. Thomson, and M. Small, “Free radical activity in type 2 diabetes,” Diabetic Medicine, vol. 7, no. 1, pp. 27–30, 1990. View at Publisher · View at Google Scholar · View at Scopus
  31. E. A. Yazıcı, H. Paşaoğlu, D. Yücel et al., “Plasma total thiol and erythrocyte reduced glutathione levels in patients with type II diabetes mellitus,” Turkiye Klinikleri Journal of Medical Sciences, vol. 22, pp. 487–492, 2002. View at Google Scholar
  32. H. M. Uçgun, A. Sevinç, and C. Camcı, “Plasma lipid peroxidation products and antioxidant enzyme activities in patients with type 2 diabetes mellitus,” Acta Diabetologica, vol. 39, no. 3, pp. 117–122, 2002. View at Publisher · View at Google Scholar · View at Scopus
  33. C. Caner, A. Vural Özeç, H. Aydin et al., “Diyabetik ve Diyabetik Olmayan Katarakt Hastalarında Hümör Aközde ve Serumda Total Oksidatif Stres, Total Antioksidan Kapasite, Paraoksonaz, Arilesteraz ve Lipidperoksidaz Seviyelerinin Karşılaştırılması,” Turkish Journal of Ophthalmology, vol. 42, pp. 47–52, 2012. View at Google Scholar